Included are all patients with uveitis of all anatomical locations (anterior, intermedia, posterior uveitis as well as panuveitis), regardless of the etiology.
Conditions
Interventions
Group 1: Prospective and retrospective analysis of all patients aged seven years and older who received a diagnosis of uveitis since 2006.
Sponsors
Universitätsklinikum Heidelberg
Eligibility
Sex/Gender
All
Age
7 Years to No maximum
Inclusion criteria
Inclusion criteria: Data analysis of patients who have been in treatment since 2006. Patients who are capable of consenting to study participation after appropriate information (for adults: their own capacity to consent), for minors (< 18 years): written consent of the legal guardian; in addition, age- and developmentally appropriate information for the child or adolescent and obtaining their consent.
Exclusion criteria
Exclusion criteria: Patients who do not wish to participate in the study; those with mental illnesses, cognitive impairments, or neurodevelopmental delays to such an extent that informed consent to study participation would be impossible or significantly restricted; those for whom legally and ethically justifiable consent to study participation cannot be obtained from their legal guardians for the same reasons; insufficient German language skills
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study describes the long-term functional course and the occurrence of vision-threatening complications in various forms of uveitis, as well as the recording of disease activity and long-term disease control under local and systemic therapy. Clinical routine data from regular ophthalmological examinations, external findings brought in by patients, and, if performed as part of routine care, imaging data and clinically indicated biospecimens will be recorded. The timeline for participating patients corresponds exactly to their regular follow-up visits at the uveitis center, so no additional time is required. No additional study consultations or extra appointments will be scheduled. At each regular visit, the aforementioned data, if available, will be entered into the study documentation. Adult patients will be asked to complete a voluntary quality-of-life questionnaire every three months. The questionnaire responses will be digitally recorded and stored using the IMI-EDC (Institute for Medical Informatics - Electronic Data Capture) application developed by the Institute for Medical Informatics at Heidelberg University. | — |
Secondary
| Measure | Time frame |
|---|---|
| Characterization of the course of treatment and the identification of clinical and laboratory factors associated with adverse outcomes and complications. | — |
Countries
Germany
Contacts
Public ContactLucy Kessler
Universitätsklinikum Heidelberg
Outcome results
None listed